Generative AI In Gaming Market Size, Industry Trends, Share, Market Analysis, Key Drivers, Top Major Players And Forecast To 2033

Overview and Scope
Point-of-care (POC) coagulation testing devices are portable, easy-to-use medical devices used to assess the clotting ability of blood outside of a traditional laboratory setting. They are designed to provide rapid and accurate results, allowing healthcare providers to make immediate treatment decisions for patients with coagulation disorders or those at risk of abnormal bleeding or clotting.

Sizing and Forecast
The point-of-care (POC) coagulation testing devices market size has grown strongly in recent years. It will grow from $1.93 billion in 2023 to $2.12 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing prevalence of infectious and chronic diseases, increasing geriatric population, increasing use of miniaturized portable instruments, growing use of biomarker profiling, and growing demand for personalized medicine.

The point-of-care (POC) coagulation testing devices market size is expected to see strong growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing emphasis on wellness and preventive healthcare, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and rise of telemedicine. Major trends in the forecast period include next-generation sequencing (NGS) integration, RNA detection and analysis, single-cell PCR analysis, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), artificial intelligence (AI) and data analytics.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-devices-global-market-report

The point-of-care (POC) coagulation testing devices market covered in this report is segmented –

1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users

North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2023. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=15636&type=smp

Major Driver Impacting Market Growth
The rise in the prevalence of blood clotting disorders is expected to propel the growth of the point-of-care (POC) coagulation testing devices market going forward. Blood clotting disorders impair the blood’s ability to clot properly. Lifestyle factors can contribute to blood clotting disorders, including smoking, excessive alcohol consumption, and a sedentary lifestyle. These behaviors can affect blood vessel health, clotting factor levels, and blood flow, increasing the risk of abnormal clot formation. POC coagulation testing devices enable healthcare providers to quickly assess a patient’s coagulation status, allowing for timely adjustments to medication dosages and treatment plans. For instance, in December 2022, according to the annual global survey of 188 countries conducted by the World Federation of Hemophilia, a Canada-based international non-profit organization, in 2021, there were 429,232 individuals affected by bleeding disorders, comprising 256,840 with hemophilia, a genetic disorder characterized by insufficient clotting factors in the blood, 98,293 with von Willebrand disease (VWD), a condition where the blood does not clot effectively, and 74,099 with other bleeding disorders. This marks a 9% rise from the previous year, with hemophilia cases increasing by 6%, von Willebrand disease cases by 12%, and other bleeding disorders by 15%. Therefore, the rise in the prevalence of blood clotting disorders drives the growth of the point-of-care (POC) coagulation testing devices market.

Key Industry Players
Major companies operating in the point-of-care (POC) coagulation testing devices market are  Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, Sonora Quest Laboratories, 23andMe Holding Co, Thorne HealthTech Inc., Metropolis Healthcare Limited, Color Health Inc, LetsGetChecked Inc., Ambry Genetics Corporation, MyHeritage Ltd, Genova Diagnostics Inc., Everlywell Inc., Complete Genomics Incorporated, DanteLabs Inc., HemoSonics LLC, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC, Full Genomes Corporation Inc., Ulta Lab Tests LLC, WellnessFX Inc., Any Lab Test Now Inc.

The point-of-care (poc) coagulation testing devices market report table of contents includes:

1. Executive Summary

2. Point-of-Care (POC) Coagulation Testing Devices Characteristics

3. Point-of-Care (POC) Coagulation Testing Devices Trends And Strategies

4. Point-of-Care (POC) Coagulation Testing Devices – Macro Economic Scenario

5. Global Point-of-Care (POC) Coagulation Testing Devices Size and Growth

…..

32. Global Point-of-Care (POC) Coagulation Testing Devices Competitive Benchmarking

33. Global Point-of-Care (POC) Coagulation Testing Devices Competitive Dashboard

34. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Devices

35. Point-of-Care (POC) Coagulation Testing Devices Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model